Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Cerebroprotein Hydrolysate (30mg) Injection
Therapeutic Category
Neurology
Dosage Form
Injection
Packaging Type
Vial
Packaging
30mg
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Ceretime 30 Injection containing Cerebroprotein Hydrolysate is used for supporting neurological function and cognitive health. It helps promote nerve cell activity and supports neuroprotective care.
Cerebroprotein Hydrolysate works by supplying neuropeptides and amino acids that help support neuronal metabolism, cognitive function, and nerve regeneration processes.
The injection is widely prescribed in neurology and neuro-rehabilitation practice for supportive management of neurological and cognitive disorders, leading to consistent prescription demand.
With increasing awareness regarding neurological wellness and cognitive care, this product offers strong business potential for retailers and distributors. Its neuro-supportive action, broad therapeutic relevance, and steady market demand make it a reliable product for growth in the neuro care segment.
Some patients may experience headache, dizziness, nausea, sweating, agitation, or injection site reactions. Rarely, allergic reactions or hypersensitivity responses may occur and require immediate medical attention.
Ceretime 30 Injection is indicated for stroke rehabilitation, dementia, Alzheimer’s disease, traumatic brain injury, cognitive impairment, neuropathy, and other neurological disorders requiring neuroprotective support. It helps improve cognitive function, memory, concentration, and neurological recovery.
This injection should be administered strictly under medical supervision by qualified healthcare professionals. Use cautiously in patients with epilepsy or severe kidney disorders. Follow the prescribed dosage and treatment schedule carefully.
Store below 25°C, protected from direct sunlight and freezing. Keep the ampoule in its original packaging and out of reach of children.
Composition : Ceftriaxone (250mg) + Sulbactam (125mg)
Composition : Ceftriaxone (250mg) + Tazobactum (31.25mg)
Composition : Ceftriaxone (500mg)
Composition : Ceftriaxone (500mg) + Sulbactam (250mg)
Composition : Cefuroxime (1500mg)
Composition : Cefuroxime (1.5gm)
Composition : Cefuroxime (1500mg) + Sulbactam (750mg)
Composition : Clarithromycin (500mg) Injection
Composition : Clindamycin (300mg) Injection
Composition : Clindamycin (600mg)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Cerebroprotein Hydrolysate 30mg Injection has strong demand in the neurology, neuro-rehabilitation, and critical-care segment, making it a valuable product for distributors, wholesalers, and pharma franchise partners focusing on CNS injectable portfolios.
Distributors and agencies can benefit from consistent hospital usage for brain and neurological recovery support under medical supervision. Cerebroprotein Hydrolysate is a neuropeptide preparation derived from brain proteins Commonly used in stroke recovery, head injury, cognitive impairment, dementia support, and neurological rehabilitation cases Helps support neuronal repair, brain metabolism, and functional recovery after brain injury Widely used in neurology departments, ICUs, and rehabilitation centers Prescribed by neurologists and critical-care specialists This strengthens a specialized neurology and neuro-recovery injectable portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Cerebroprotein Hydrolysate Injection with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from hospital and ICU demand, neuro-rehabilitation usage, repeat institutional procurement, and specialist-driven prescriptions, along with reliable supply chain support and strong margins in the neuro-critical care segment.
Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to explore PCD pharma franchise opportunities, discuss pricing and business terms, obtain monopoly territory rights, and benefit from professional marketing support, quality pharmaceutical products, and a dependable supply chain for neurology-focused business growth.